Brief: Lee's Pharmaceutical Holdings Sees Increase in HY Unaudited Net Profit
13/08/2020 11:32
Aug 13 (Reuters) - Lee's Pharmaceutical Holdings Ltd
0950.HK :
* LEE'S PHARMACEUTICAL HOLDINGS LTD - ANTICIPATED THAT
UNAUDITED
NET PROFIT ATTRIBUTABLE FOR SIX MONTHS WILL INCREASE BY ABOUT
150%,
* LEE'S PHARMACEUTICAL- EXPECTED RESULT DUE TO ONE-OFF
COMPENSATION INCOME RECOGNISED BY CO UPON EARLY TERMINATION OF
PRODUCT LICENSE OF ZANIDIP
Source text for Eikon: urn:newsml:reuters.com:*:nHKS13QjtQ
Further company coverage: 0950.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lee's Pharmaceutical Holdings
See all newsHong Kong's Lee's Pharmaceutical H1 profit jumps on higher-margin product sales
Brief: Lee's Pharmaceutical Expects H1 Net Profit Of HK$85 Million-HK$95 Million
Brief: Lee's Pharmaceutical Says Investigational New Drug Application For ADC Project ZK2401 Accepted By NMPA
Brief: Ashlins Pharmaceuticals And Lee's Pharm Announce Exclusive License And Supply Agreement Valued At Up To $31 Million
Brief: Lee's Pharmaceutical Says Entered Licensing Agreement With Ashlins Ocular Pharmaceuticals